For US residents only.

Understanding Treatment

VOTRIENT

Understanding Treatment Understanding Treatment

Talking to your team about treatment

You may have questions as you consider treatment options, like VOTRIENT® (pazopanib) tablets, for metastatic renal cell carcinoma (advanced kidney cancer). It may be hard to know how all of the information you’ve gathered applies to your diagnosis. That’s why working with your health care team to make decisions is so important.

 

When you talk with your health care provider about possible treatments for metastatic renal cell carcinoma (advanced kidney cancer), you may discuss some of the following:

In some cases, a medicine that was working to treat a patient’s cancer may stop working. This is called treatment resistance. If this happens, your health care provider will talk with you about other treatment options to be considered. Every patient’s experience with treatment is different.

 

Some patients may see a decrease in the number of cancer cells in their body. Some patients may not see these results, but instead will have long periods of “stable” disease. This means that the cancer in their body is neither growing nor shrinking.

 

Although you may not be able to know exactly what will happen with metastatic renal cell carcinoma (advanced kidney cancer) and your treatment, your health care team will partner with you to determine a treatment plan that works best for you. Keep in mind that you are never alone in your care. Your team is there to support you every step of the way. 

 

Questions about VOTRIENT?

Find out more about treatment with VOTRIENT and remember that you can talk to your health care team any time.